![](/img/cover-not-exists.png)
Clinical efficacy of daratumumab, pomalidomide, and dexamethasone in patients with relapsed or refractory myeloma: Utility of re‐treatment with daratumumab among refractory patients
Nooka, Ajay K., Joseph, Nisha S., Kaufman, Jonathan L., Heffner, Leonard T., Gupta, Vikas A., Gleason, Charise, Boise, Lawrence H., Lonial, SagarJournal:
Cancer
DOI:
10.1002/cncr.32178
Date:
May, 2019
File:
PDF, 504 KB
2019